Type
. Role of granulysin in immunity to leprosy. Leprosy review [Internet]. 2000;71 Suppl:S115; discussion S115-6. Available from: http://leprev.ilsl.br/pdfs/2000/v71s1/pdf/v71s1a24.pdf
Type
. Steroids in leprosy type 1 (reversal) reactions: mechanisms of action and effectiveness. Leprosy review [Internet]. 2000;71 Suppl:S111-4. Available from: http://leprev.ilsl.br/pdfs/2000/v71s1/pdf/v71s1a23.pdf
Type
. The epidemiology of reactions and nerve damage. Leprosy review [Internet]. 2000;71 Suppl:S106-10. Available from: http://leprev.ilsl.br/pdfs/2000/v71s1/pdf/v71s1a22.pdf
Type
. The new challenges for chemotherapy research. Leprosy review [Internet]. 2000;71 Suppl:S100-4. Available from: http://leprev.ilsl.br/pdfs/2000/v71s1/pdf/v71s1a21.pdf
Type
. Clinical screening for ulnar nerve damage in leprosy patients. Journal of neurology. 2000;247(12):966-7.
Type
. Causes of enlarged corneal nerves. International ophthalmology clinics. 2001;41(1):13-23.
Type
. [Guideline for the treatment of Hansen's disease in Japan]. Nihon Hansenbyo Gakkai zasshi = Japanese journal of leprosy : official organ of the Japanese Leprosy Association. 2000;69(3):157-77.
Type
. Leprosy lipid provides the key to Schwann cell entry. Trends in microbiology. 2001;9(2):52-4.
Type
. Molecular basis for the peripheral nerve predilection of Mycobacterium leprae. Current opinion in microbiology. 2001;4(1):21-7.
Type
. Ocular complications of leprosy in Cameroon. Acta ophthalmologica Scandinavica [Internet]. 2001;79(1):31-3. Available from: http://onlinelibrary.wiley.com/doi/10.1034/j.1600-0420.2001.079001031.x/epdf